O	O	O	0	10	Unexpected	Unexpecte	B-VP	VBN	O	3	AMOD	O
O	O	O	11	14	and	and	O	CC	O	3	AMOD	O
O	O	O	15	26	coordinated	coordinate	B-VP	VBN	O	4	NMOD	O
O	O	O	27	37	expression	expression	B-NP	NN	O	0	ROOT	O
O	O	O	38	40	of	of	B-PP	IN	O	4	NMOD	O
T1	B-Protein	B-Protein	41	44	Spi	Spi	B-NP	NN	B-protein	7	NMOD	B-protein
T1	I-Protein	I-Protein	44	45	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T1	I-Protein	I-Protein	45	46	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	O	46	47	,	,	O	,	O	16	P	O
T2	B-Protein	B-Protein	48	51	Fli	Fli	B-NP	NNP	B-protein	11	NMOD	B-protein
T2	I-Protein	I-Protein	51	52	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T2	I-Protein	I-Protein	52	53	1	1	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	53	54	,	,	O	,	O	16	P	O
O	O	O	55	58	and	and	O	CC	O	16	NMOD	O
O	O	O	59	73	megakaryocytic	megakaryocytic	B-NP	JJ	B-DNA	16	NMOD	B-DNA
O	O	O	74	79	genes	gene	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	80	82	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	83	87	four	four	B-NP	CD	O	23	NMOD	O
T3	B-Protein	B-Protein	88	91	Epo	Epo	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	91	92	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	92	101	dependent	dependent	I-NP	JJ	O	23	NMOD	O
O	O	O	102	106	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	O	107	112	lines	line	I-NP	NNS	O	17	PMOD	O
O	O	O	113	124	established	establish	B-VP	VBN	O	23	NMOD	O
O	O	O	125	129	from	from	B-PP	IN	O	24	VMOD	O
O	O	O	130	140	transgenic	transgenic	B-NP	JJ	O	27	NMOD	O
O	O	O	141	145	mice	mouse	I-NP	NNS	O	25	PMOD	O
O	O	O	146	156	displaying	display	B-VP	VBG	O	27	NMOD	O
O	O	O	157	166	erythroid	erythroid	B-NP	JJ	O	31	AMOD	O
O	O	O	166	167	-	-	I-NP	HYPH	O	31	AMOD	O
O	O	O	167	175	specific	specific	I-NP	JJ	O	32	NMOD	O
O	O	O	176	186	expression	expression	I-NP	NN	O	28	OBJ	O
O	O	O	187	189	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	190	191	a	a	B-NP	DT	O	38	NMOD	O
O	O	O	192	207	thermosensitive	thermosensitive	I-NP	JJ	B-protein	38	NMOD	B-protein
O	O	O	208	212	SV40	SV40	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	213	214	T	T	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	215	222	antigen	antigen	I-NP	NN	I-protein	33	PMOD	I-protein
O	O	O	222	223	.	.	O	.	O	4	P	O

O	O	O	225	229	Most	Most	B-NP	RBS	O	4	NMOD	O
O	O	O	230	245	erythroleukemic	erythroleukemic	I-NP	JJ	B-cell_line	4	NMOD	B-cell_line
O	O	O	246	250	cell	cell	I-NP	NN	I-cell_line	4	NMOD	I-cell_line
O	O	O	251	256	lines	line	I-NP	NNS	I-cell_line	8	SUB	I-cell_line
O	O	O	257	268	established	establish	B-VP	VBN	O	4	NMOD	O
O	O	O	269	271	in	in	B-ADVP	FW	O	5	VMOD	O
O	O	O	272	277	vitro	vitro	I-ADVP	FW	O	6	AMOD	O
O	O	O	278	287	coexpress	coexpres	B-VP	VBP	O	0	ROOT	O
O	O	O	288	300	erythrocytic	erythrocytic	B-NP	JJ	B-protein	11	AMOD	B-protein
O	O	O	301	304	and	and	I-NP	CC	I-protein	11	AMOD	I-protein
O	O	O	305	319	megakaryocytic	megakaryocytic	I-NP	JJ	I-protein	12	NMOD	I-protein
O	O	O	320	327	markers	marker	I-NP	NNS	I-protein	8	OBJ	I-protein
O	O	O	328	332	that	that	B-NP	WDT	O	12	NMOD	O
O	O	O	333	338	often	often	B-ADVP	RB	O	15	VMOD	O
O	O	O	339	342	are	be	B-VP	VBP	O	13	SBAR	O
O	O	O	343	353	associated	associate	I-VP	VBN	O	15	VC	O
O	O	O	354	358	with	with	B-PP	IN	O	16	VMOD	O
O	O	O	359	369	expression	expression	B-NP	NN	O	17	PMOD	O
O	O	O	370	372	of	of	B-PP	IN	O	18	NMOD	O
T4	B-Protein	B-Protein	373	376	Spi	Spi	B-NP	NN	B-protein	22	NMOD	B-protein
T4	I-Protein	I-Protein	376	377	-	-	B-NP	HYPH	I-protein	22	P	I-protein
T4	I-Protein	I-Protein	377	378	1	1	I-NP	CD	I-protein	19	PMOD	I-protein
O	O	O	379	382	and	and	O	CC	O	15	VMOD	O
O	O	O	382	383	/	/	B-VP	SYM	O	23	PMOD	O
O	O	O	383	385	or	or	O	CC	O	30	NMOD	O
T5	B-Protein	B-Protein	386	389	Fli	Fli	O	AFX	B-protein	30	NMOD	B-protein
T5	I-Protein	I-Protein	389	390	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T5	I-Protein	I-Protein	390	391	1	1	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	O	392	405	transcription	transcription	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	406	413	factors	factor	I-NP	NNS	I-protein	24	OBJ	I-protein
O	O	O	414	419	known	know	B-VP	VBN	O	30	NMOD	O
O	O	O	420	422	as	as	B-PP	IN	O	31	VMOD	O
O	O	O	423	438	transactivators	transactivator	B-NP	NNS	B-protein	32	PMOD	B-protein
O	O	O	439	441	of	of	B-PP	IN	O	33	NMOD	O
T21	B-Entity	B-Entity	442	455	megakaryocyte	megakaryocyte	B-NP	NN	B-DNA	38	NMOD	B-DNA
T21	I-Entity	I-Entity	455	456	-	-	B-NP	HYPH	I-DNA	38	NMOD	I-DNA
T21	I-Entity	I-Entity	456	464	specific	specific	I-NP	JJ	I-DNA	38	NMOD	I-DNA
T21	I-Entity	I-Entity	465	474	promoters	promoter	I-NP	NNS	I-DNA	34	PMOD	I-DNA
O	O	O	474	475	.	.	O	.	O	8	P	O

O	O	O	476	478	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	479	482	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	483	490	present	present	I-NP	JJ	O	4	NMOD	O
O	O	O	491	496	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	496	497	,	,	O	,	O	7	P	O
O	O	O	498	500	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	501	509	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	510	513	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	514	525	possibility	possibility	I-NP	NN	O	7	OBJ	O
O	O	O	526	528	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	529	541	establishing	establish	B-VP	VBG	O	10	PMOD	O
O	O	O	542	545	new	new	B-NP	JJ	B-cell_line	14	NMOD	B-cell_line
O	O	O	546	550	cell	cell	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	551	556	lines	line	I-NP	NNS	I-cell_line	11	OBJ	I-cell_line
O	O	O	557	564	keeping	keep	B-VP	VBG	O	14	NMOD	O
O	O	O	565	573	strictly	strictly	B-NP	RB	O	17	AMOD	O
O	O	O	574	583	erythroid	erythroid	I-NP	JJ	O	19	AMOD	O
O	O	O	583	584	-	-	I-NP	HYPH	O	19	AMOD	O
O	O	O	584	592	specific	specific	I-NP	JJ	O	20	NMOD	O
O	O	O	593	603	properties	property	I-NP	NNS	O	15	OBJ	O
O	O	O	604	606	in	in	B-ADVP	FW	O	11	VMOD	O
O	O	O	607	612	vitro	vitro	I-ADVP	FW	O	21	AMOD	O
O	O	O	613	620	through	through	B-PP	IN	O	11	VMOD	O
O	O	O	621	624	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	625	633	targeted	target	I-NP	VBN	O	27	AMOD	O
O	O	O	634	637	and	and	I-NP	CC	O	27	AMOD	O
O	O	O	638	649	conditional	conditional	I-NP	JJ	O	28	NMOD	O
O	O	O	650	665	immortalization	immortalization	I-NP	NN	O	23	PMOD	O
O	O	O	666	668	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	669	681	erythrocytic	erythrocytic	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	O	682	693	progenitors	progenitor	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	693	694	.	.	O	.	O	7	P	O

O	O	O	695	698	For	For	B-PP	IN	O	6	VMOD	O
O	O	O	699	703	that	that	B-NP	DT	O	3	NMOD	O
O	O	O	704	711	purpose	purpose	I-NP	NN	O	1	PMOD	O
O	O	O	711	712	,	,	O	,	O	6	P	O
O	O	O	713	715	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	716	727	established	establish	B-VP	VBD	O	0	ROOT	O
O	O	O	728	735	several	several	B-NP	JJ	O	8	NMOD	O
O	O	O	736	741	lines	line	I-NP	NNS	O	6	OBJ	O
O	O	O	742	744	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	745	755	transgenic	transgenic	B-NP	JJ	O	11	NMOD	O
O	O	O	756	760	mice	mouse	I-NP	NNS	O	9	PMOD	O
O	O	O	761	771	displaying	display	B-VP	VBG	O	11	NMOD	O
O	O	O	772	781	erythroid	erythroid	B-NP	JJ	O	15	AMOD	O
O	O	O	781	782	-	-	I-NP	HYPH	O	15	AMOD	O
O	O	O	782	790	specific	specific	I-NP	JJ	O	16	NMOD	O
O	O	O	791	801	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	O	802	804	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	805	806	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	807	822	thermosensitive	thermosensitive	I-NP	JJ	B-protein	22	NMOD	B-protein
O	O	O	823	827	SV40	SV40	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	828	829	T	T	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	830	837	antigen	antigen	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	837	838	.	.	O	.	O	6	P	O

O	O	O	839	841	As	As	B-SBAR	IN	O	7	VMOD	O
O	O	O	842	850	expected	expect	B-VP	VBN	O	1	SBAR	O
O	O	O	850	851	,	,	O	,	O	7	P	O
O	O	O	852	857	these	these	B-NP	DT	O	6	NMOD	O
O	O	O	858	868	transgenic	transgenic	I-NP	JJ	O	6	NMOD	O
O	O	O	869	873	mice	mouse	I-NP	NNS	O	7	SUB	O
O	O	O	874	883	developed	develop	B-VP	VBD	O	0	ROOT	O
O	O	O	884	896	splenomegaly	splenomegaly	B-NP	NN	O	7	OBJ	O
O	O	O	897	900	due	due	B-ADJP	JJ	O	10	PMOD	O
O	O	O	901	903	to	to	B-PP	TO	O	7	VMOD	O
O	O	O	904	907	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	908	915	massive	massive	I-NP	JJ	O	13	NMOD	O
O	O	O	916	929	amplification	amplification	I-NP	NN	O	10	PMOD	O
O	O	O	930	932	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	933	936	Ter	Ter	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	O	937	940	119	119	I-NP	CD	I-cell_line	20	NMOD	I-cell_line
O	O	O	941	949	positive	positive	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	950	959	erythroid	erythroid	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	960	969	nucleated	nucleated	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	970	975	cells	cell	I-NP	NNS	I-cell_line	14	PMOD	I-cell_line
O	O	O	976	986	expressing	express	B-VP	VBG	O	20	NMOD	O
O	O	O	987	988	T	T	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	989	996	antigen	antigen	I-NP	NN	I-protein	21	OBJ	I-protein
O	O	O	996	997	.	.	O	.	O	7	P	O

O	O	O	998	1005	Despite	Despite	B-PP	IN	O	19	VMOD	O
O	O	O	1006	1010	this	this	B-NP	DT	O	4	NMOD	O
O	O	O	1011	1018	drastic	drastic	I-NP	JJ	O	4	NMOD	O
O	O	O	1019	1025	effect	effect	I-NP	NN	O	1	PMOD	O
O	O	O	1026	1028	in	in	B-ADVP	FW	O	6	AMOD	O
O	O	O	1029	1033	vivo	vivo	I-ADVP	FW	O	4	NMOD	O
O	O	O	1033	1034	,	,	O	,	O	19	P	O
O	O	O	1035	1038	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1039	1041	in	in	I-NP	FW	O	10	AMOD	O
O	O	O	1042	1047	vitro	vitro	I-NP	FW	O	11	NMOD	O
O	O	O	1048	1063	immortalization	immortalization	I-NP	NN	O	19	SUB	O
O	O	O	1064	1066	of	of	B-PP	IN	O	11	NMOD	O
T6	B-Protein	B-Protein	1067	1081	erythropoietin	erythropoietin	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	1081	1082	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	1082	1091	dependent	dependent	I-NP	JJ	O	17	NMOD	O
O	O	O	1092	1101	erythroid	erythroid	I-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	1102	1113	progenitors	progenitor	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	1114	1126	unexpectedly	unexpectedly	B-ADVP	RB	O	19	VMOD	O
O	O	O	1127	1135	occurred	occur	B-VP	VBD	O	30	VMOD	O
O	O	O	1136	1138	at	at	B-PP	IN	O	19	VMOD	O
O	O	O	1139	1142	low	low	B-NP	JJ	O	22	NMOD	O
O	O	O	1143	1152	frequency	frequency	I-NP	NN	O	20	PMOD	O
O	O	O	1152	1153	,	,	O	,	O	30	P	O
O	O	O	1154	1157	and	and	O	CC	O	30	VMOD	O
O	O	O	1158	1161	all	all	B-NP	DT	O	28	NMOD	O
O	O	O	1162	1166	four	four	I-NP	CD	O	28	NMOD	O
O	O	O	1167	1171	cell	cell	I-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	O	1172	1177	lines	line	I-NP	NNS	I-cell_line	30	SUB	I-cell_line
O	O	O	1178	1189	established	establish	B-VP	VBN	O	28	NMOD	O
O	O	O	1190	1199	expressed	express	B-VP	VBD	O	0	ROOT	O
O	O	O	1200	1204	both	both	O	CC	O	38	NMOD	O
O	O	O	1205	1217	erythrocytic	erythrocytic	O	JJ	B-protein	34	NMOD	B-protein
O	O	O	1218	1219	(	(	O	(	I-protein	34	NMOD	I-protein
O	O	O	1219	1226	globins	globin	B-NP	NNS	I-protein	38	NMOD	I-protein
O	O	O	1226	1227	)	)	O	)	I-protein	34	NMOD	I-protein
O	O	O	1228	1231	and	and	O	CC	I-protein	38	NMOD	I-protein
O	O	O	1232	1246	megakaryocytic	megakaryocytic	B-NP	JJ	I-protein	38	NMOD	I-protein
O	O	O	1247	1254	markers	marker	I-NP	NNS	I-protein	57	NMOD	I-protein
O	O	O	1255	1256	(	(	O	(	O	46	DEP	O
T7	B-Protein	B-Protein	1256	1268	glycoprotein	glycoprotein	B-NP	NN	B-protein	41	NMOD	B-protein
T7	I-Protein	I-Protein	1269	1272	IIb	IIb	I-NP	NN	I-protein	44	NMOD	I-protein
O	O	O	1272	1273	,	,	O	,	O	44	P	O
T8	B-Protein	B-Protein	1274	1282	platelet	platelet	B-NP	NN	B-protein	44	NMOD	B-protein
T8	I-Protein	I-Protein	1283	1289	factor	factor	I-NP	NN	I-protein	46	DEP	I-protein
T8	I-Protein	I-Protein	1290	1291	4	4	I-NP	CD	I-protein	44	NMOD	I-protein
O	O	O	1291	1292	)	)	O	)	O	38	NMOD	O
O	O	O	1293	1295	as	as	B-CONJP	RB	O	57	NMOD	O
O	O	O	1296	1300	well	well	I-CONJP	RB	O	47	DEP	O
O	O	O	1301	1303	as	as	I-CONJP	IN	O	47	DEP	O
T9	B-Protein	B-Protein	1304	1307	Spi	Spi	B-NP	NN	B-protein	51	NMOD	B-protein
T9	I-Protein	I-Protein	1307	1308	-	-	B-NP	HYPH	I-protein	57	NMOD	I-protein
T9	I-Protein	I-Protein	1308	1309	1	1	I-NP	CD	I-protein	51	NMOD	I-protein
O	O	O	1310	1313	and	and	O	CC	O	57	NMOD	O
T10	B-Protein	B-Protein	1314	1317	Fli	Fli	B-NP	NNP	O	57	NMOD	O
T10	I-Protein	I-Protein	1317	1318	-	-	B-NP	HYPH	O	57	NMOD	O
T10	I-Protein	I-Protein	1318	1319	1	1	I-NP	CD	B-RNA	57	NMOD	B-RNA
O	O	O	1320	1331	transcripts	transcript	I-NP	NNS	I-RNA	30	OBJ	I-RNA
O	O	O	1332	1334	at	at	B-PP	IN	O	30	VMOD	O
O	O	O	1335	1345	permissive	permissive	B-NP	JJ	O	60	NMOD	O
O	O	O	1346	1357	temperature	temperature	I-NP	NN	O	58	PMOD	O
O	O	O	1357	1358	.	.	O	.	O	30	P	O

O	O	O	1359	1368	Switching	Switch	B-VP	VBG	O	8	SUB	O
O	O	O	1369	1372	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	1373	1378	cells	cell	I-NP	NNS	O	1	OBJ	O
O	O	O	1379	1381	to	to	B-PP	TO	O	1	VMOD	O
O	O	O	1382	1385	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1386	1399	nonpermissive	nonpermissive	I-NP	JJ	O	7	NMOD	O
O	O	O	1400	1411	temperature	temperature	I-NP	NN	O	4	PMOD	O
O	O	O	1412	1415	led	lead	B-VP	VBD	O	0	ROOT	O
O	O	O	1416	1418	to	to	B-PP	TO	O	8	VMOD	O
O	O	O	1419	1420	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1421	1427	marked	marked	I-NP	JJ	O	12	NMOD	O
O	O	O	1428	1436	increase	increase	I-NP	NN	O	19	NMOD	O
O	O	O	1437	1439	in	in	B-PP	IN	O	12	NMOD	O
T22	B-Entity	B-Entity	1440	1446	globin	globin	B-NP	NN	B-DNA	16	NMOD	B-DNA
T22	I-Entity	I-Entity	1447	1451	gene	gene	I-NP	NN	I-DNA	16	NMOD	I-DNA
O	O	O	1452	1462	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	1463	1466	and	and	O	CC	O	19	NMOD	O
O	O	O	1467	1478	concomitant	concomitant	B-NP	JJ	O	19	NMOD	O
O	O	O	1479	1487	decrease	decrease	I-NP	NN	O	9	PMOD	O
O	O	O	1488	1490	in	in	B-PP	IN	O	19	NMOD	O
O	O	O	1491	1501	expression	expression	B-NP	NN	O	20	PMOD	O
O	O	O	1502	1504	of	of	B-PP	IN	O	21	NMOD	O
T11	B-Protein	B-Protein	1505	1508	Spi	Spi	B-NP	NN	B-protein	24	NMOD	B-protein
T11	I-Protein	I-Protein	1508	1509	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T11	I-Protein	I-Protein	1509	1510	1	1	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	O	1510	1511	,	,	O	,	O	24	P	O
T12	B-Protein	B-Protein	1512	1515	Fli	Fli	B-NP	NNP	B-protein	28	NMOD	B-protein
T12	I-Protein	I-Protein	1515	1516	-	-	B-NP	HYPH	I-protein	24	P	I-protein
T12	I-Protein	I-Protein	1516	1517	1	1	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	O	1517	1518	,	,	O	,	O	24	P	O
O	O	O	1519	1522	and	and	O	CC	O	33	NMOD	O
O	O	O	1523	1537	megakaryocytic	megakaryocytic	B-NP	JJ	B-DNA	33	NMOD	B-DNA
O	O	O	1538	1543	genes	gene	I-NP	NNS	I-DNA	22	PMOD	I-DNA
O	O	O	1544	1546	in	in	B-PP	IN	O	19	NMOD	O
O	O	O	1547	1549	an	an	B-NP	DT	O	39	NMOD	O
T13	B-Protein	B-Protein	1550	1564	erythropoietin	erythropoietin	I-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	1564	1565	-	-	B-NP	HYPH	O	39	NMOD	O
O	O	O	1565	1574	dependent	dependent	I-NP	JJ	O	39	NMOD	O
O	O	O	1575	1581	manner	manner	I-NP	NN	O	34	PMOD	O
O	O	O	1581	1582	.	.	O	.	O	8	P	O

O	O	O	1583	1596	Interestingly	Interestingly	B-ADVP	RB	O	15	VMOD	O
O	O	O	1596	1597	,	,	O	,	O	15	P	O
O	O	O	1598	1606	enhanced	enhance	B-VP	VBN	O	4	NMOD	O
O	O	O	1607	1617	expression	expression	B-NP	NN	O	13	NMOD	O
O	O	O	1618	1620	of	of	B-PP	IN	O	4	NMOD	O
T14	B-Protein	B-Protein	1621	1624	Spi	Spi	B-NP	NN	B-protein	5	PMOD	B-protein
T14	I-Protein	I-Protein	1624	1625	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T14	I-Protein	I-Protein	1625	1626	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	O	1627	1630	and	and	O	CC	O	13	NMOD	O
T15	B-Protein	B-Protein	1631	1634	Fli	Fli	B-NP	NNP	O	13	NMOD	O
T15	I-Protein	I-Protein	1634	1635	-	-	B-NP	HYPH	B-DNA	13	NMOD	B-DNA
T15	I-Protein	I-Protein	1635	1636	1	1	I-NP	CD	I-DNA	13	NMOD	I-DNA
O	O	O	1637	1642	genes	gene	I-NP	NNS	I-DNA	15	SUB	I-DNA
O	O	O	1643	1650	already	already	B-ADVP	RB	O	15	VMOD	O
O	O	O	1651	1654	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1655	1663	detected	detect	I-VP	VBN	O	15	VC	O
O	O	O	1664	1666	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	1667	1670	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1671	1674	Ter	Ter	I-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	O	1675	1678	119	119	I-NP	CD	I-cell_line	23	NMOD	I-cell_line
O	O	O	1679	1687	positive	positive	I-NP	JJ	I-cell_line	23	NMOD	I-cell_line
O	O	O	1688	1692	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	1693	1703	population	population	I-NP	NN	I-cell_line	17	PMOD	I-cell_line
O	O	O	1704	1706	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1707	1717	transgenic	transgenic	B-NP	JJ	O	27	NMOD	O
O	O	O	1718	1722	mice	mouse	I-NP	NNS	O	27	NMOD	O
O	O	O	1723	1729	spleen	spleen	I-NP	NN	O	24	PMOD	O
O	O	O	1730	1732	in	in	B-ADVP	FW	O	29	AMOD	O
O	O	O	1733	1737	vivo	vivo	I-ADVP	FW	O	27	NMOD	O
O	O	O	1737	1738	.	.	O	.	O	15	P	O

O	O	O	1739	1746	However	However	B-ADVP	RB	O	19	VMOD	O
O	O	O	1746	1747	,	,	O	,	O	19	P	O
O	O	O	1748	1752	like	like	B-PP	IN	O	19	VMOD	O
O	O	O	1753	1759	normal	normal	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	O	1760	1763	Ter	Ter	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	O	1764	1767	119	119	I-NP	CD	I-cell_type	8	NMOD	I-cell_type
O	O	O	1768	1777	erythroid	erythroid	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	O	1778	1783	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	O	1783	1784	,	,	O	,	O	19	P	O
O	O	O	1785	1790	these	these	B-NP	DT	O	14	NMOD	O
O	O	O	1791	1794	Ter	Ter	I-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1795	1798	119	119	I-NP	CD	I-cell_line	14	NMOD	I-cell_line
O	O	O	1799	1807	positive	positive	I-NP	JJ	I-cell_line	14	NMOD	I-cell_line
O	O	O	1808	1813	cells	cell	I-NP	NNS	I-cell_line	19	SUB	I-cell_line
O	O	O	1814	1818	from	from	B-PP	IN	O	14	NMOD	O
O	O	O	1819	1829	transgenic	transgenic	B-NP	JJ	O	17	NMOD	O
O	O	O	1830	1834	mice	mouse	I-NP	NNS	O	15	PMOD	O
O	O	O	1835	1840	still	still	B-ADVP	RB	O	19	VMOD	O
O	O	O	1841	1850	expressed	express	B-VP	VBD	O	0	ROOT	O
O	O	O	1851	1855	high	high	B-NP	JJ	O	21	NMOD	O
O	O	O	1856	1862	levels	level	I-NP	NNS	O	38	NMOD	O
O	O	O	1863	1865	of	of	B-PP	IN	O	21	NMOD	O
T16	B-Protein	B-Protein	1866	1870	beta	beta	B-NP	SYM	B-protein	25	NMOD	B-protein
T16	I-Protein	I-Protein	1870	1871	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T16	I-Protein	I-Protein	1871	1877	globin	globin	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	O	1878	1881	and	and	O	CC	O	38	NMOD	O
O	O	O	1882	1886	very	very	B-NP	RB	O	28	AMOD	O
O	O	O	1887	1890	low	low	I-NP	JJ	O	30	AMOD	O
O	O	O	1891	1893	or	or	I-NP	CC	O	30	AMOD	O
O	O	O	1894	1906	undetectable	undetectable	I-NP	JJ	O	38	NMOD	O
T17	B-Protein	B-Protein	1907	1919	glycoprotein	glycoprotein	I-NP	NN	B-protein	32	NMOD	B-protein
T17	I-Protein	I-Protein	1920	1923	IIb	IIb	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	1924	1927	and	and	O	CC	O	38	NMOD	O
T18	B-Protein	B-Protein	1928	1936	platelet	platelet	B-NP	NN	B-protein	35	NMOD	B-protein
T18	I-Protein	I-Protein	1937	1943	factor	factor	I-NP	NN	I-protein	38	NMOD	I-protein
T18	I-Protein	I-Protein	1944	1945	4	4	B-NP	CD	I-protein	35	NMOD	I-protein
O	O	O	1946	1960	megakaryocytic	megakaryocytic	I-NP	JJ	I-protein	35	NMOD	I-protein
O	O	O	1961	1972	transcripts	transcript	I-NP	NNS	I-protein	19	OBJ	I-protein
O	O	O	1972	1973	.	.	O	.	O	19	P	O

O	O	O	1974	1979	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	O	1980	1988	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	O	1988	1989	,	,	O	,	O	6	P	O
O	O	O	1990	1995	these	these	B-NP	DT	O	5	NMOD	O
O	O	O	1996	2000	data	datum	I-NP	NNS	O	6	SUB	O
O	O	O	2001	2009	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	2010	2014	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	2015	2018	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	2019	2029	unexpected	unexpected	I-NP	JJ	O	10	NMOD	O
O	O	O	2030	2040	expression	expression	I-NP	NN	O	14	SUB	O
O	O	O	2041	2043	of	of	B-PP	IN	O	10	NMOD	O
T23	B-Entity	B-Entity	2044	2058	megakaryocytic	megakaryocytic	B-NP	JJ	B-DNA	13	NMOD	B-DNA
T23	I-Entity	I-Entity	2059	2064	genes	gene	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	2065	2067	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	2068	2069	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	2070	2078	specific	specific	I-NP	JJ	O	17	NMOD	O
O	O	O	2079	2087	property	property	I-NP	NN	O	14	PRD	O
O	O	O	2088	2090	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	2091	2103	immortalized	immortalize	B-NP	VBN	B-cell_line	20	NMOD	B-cell_line
O	O	O	2104	2109	cells	cell	I-NP	NNS	I-cell_line	39	NMOD	I-cell_line
O	O	O	2110	2114	that	that	B-NP	WDT	O	39	VMOD	O
O	O	O	2115	2121	cannot	cannot	B-VP	MD	O	39	VMOD	O
O	O	O	2122	2124	be	be	I-VP	VB	O	39	VMOD	O
O	O	O	2125	2134	explained	explain	I-VP	VBN	O	39	VMOD	O
O	O	O	2135	2139	only	only	B-ADVP	RB	O	39	VMOD	O
O	O	O	2140	2142	by	by	B-PP	IN	O	25	AMOD	O
O	O	O	2143	2151	enhanced	enhance	B-NP	VBN	O	28	NMOD	O
O	O	O	2152	2162	expression	expression	I-NP	NN	O	26	PMOD	O
O	O	O	2163	2165	of	of	B-PP	IN	O	28	NMOD	O
T19	B-Protein	B-Protein	2166	2169	Spi	Spi	B-NP	NN	B-protein	32	NMOD	B-protein
T19	I-Protein	I-Protein	2169	2170	-	-	B-NP	HYPH	I-protein	32	P	I-protein
T19	I-Protein	I-Protein	2170	2171	1	1	I-NP	CD	I-protein	29	PMOD	I-protein
O	O	O	2172	2175	and	and	O	CC	O	39	NMOD	O
O	O	O	2175	2176	/	/	B-VP	SYM	O	39	P	O
O	O	O	2176	2178	or	or	O	CC	O	39	NMOD	O
T20	B-Protein	B-Protein	2179	2182	Fli	Fli	O	AFX	B-protein	39	NMOD	B-protein
T20	I-Protein	I-Protein	2182	2183	-	-	O	HYPH	B-DNA	39	NMOD	B-DNA
T20	I-Protein	I-Protein	2183	2184	1	1	B-NP	CD	I-DNA	39	NMOD	I-DNA
O	O	O	2185	2190	genes	gene	I-NP	NNS	I-DNA	18	PMOD	I-DNA
O	O	O	2190	2191	.	.	O	.	O	6	P	O
